S&P Down for 4th Straight Day
The S&P 500 ticked down Tuesday, on pace for its fourth consecutive losing session, with traders weighing concerns around global trade and economic growth.The Dow Jones Industrials dropped 102.25 points to open Tuesday at 43,358.96. The much-broader index lost 56.32 points to 5,926.93The NASDAQ Composite jettisoned 349.67 points, or 1.8%, to 18,937.25. Nvidia’s 2.6% pullback led the tech-heavy index lower.Nvidia is set to report earnings Wednesday after the bell. Shares are down more than 5% in 2025, underperforming the broader market.Bitcoin prices fell below $90,000 to a three-month low. The blue-chip coin is trading almost 20% below its all-time high reached on President Donald Trump’s inauguration day.Investors are also mulling Trump’s latest remarks on trade. On Monday, Trump announced that tariffs on imports from Canada and Mexico “will go forward” after the current 30-day moratorium ends. The White House is also preparing for tighter curbs over China’s semiconductor exports, according to a report from Bloomberg News.Prices for the 10-year Treasury gained sharply, lowering yields to 4.29% from Monday’s 4.40%. Treasury prices and yields move in opposite directions.Oil prices subtracted $1.27 to $69.43 U.S. a barrel. Prices for gold dropped $22.00 an ounce to $2,941.20 U.S.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


